Changes in cardiac lipid metabolism during sepsis: The essential role of very low-density lipoprotein receptors
Changes in cardiac lipid metabolism during sepsis: The essential role of very low-density lipoprotein receptors
复制标题
DOI:
10.1016/j.cardiores.2005.11.014
复制
发表时间:
2006-02-01
影响因子:
10.8
通讯作者:
Ikeda, U
中科院分区:
文献类型:
--
作者:
Jia, LJ;Takahashi, M;Ikeda, U
Objective: Sepsis accompanies myocardial dysfunction and dynamic alterations of cardiac metabolism. We have recently demonstrated that the very low-density lipoprotein receptor (VLDL-R), which is abundantly expressed in the heart, plays a key role in energy metabolism of the fasting heart. However, little is known about the function and regulation of the VLDL-R during sepsis. In the present study, we explored lipid accumulation and VLDL-R expression in the lipopolysaccharide (LPS)-stimulated heart in vivo and regulation of VLDL-R expression in vitro.Methods and results: Electron microscopy and immunohistochemistry demonstrated that LPS significantly decreased both lipid accumulation and VLDL-R expression in the hearts of fasting mice. Treatment with LPS also downregulated VLDL-R in rat neonatal cardiac myocytes, and this downregulation was completely reversed by interleukin (IL)-1 beta receptor antagonist. IL-1 beta downregulated the expression of VLDL-R in a time- and dose-dependent manner and markedly reduced the uptake of DiI-labeled beta-VLDL but not DiI-labeled low-density lipoprotein (LDL). Use of specific pharmacologic inhibitors and short interference RNA revealed that Hsp90 was required for IL-1 beta to downregulate VLDL-R expression.Conclusions: These findings suggest that IL-1 beta is a principle mediator of changes in cardiac lipid and energy metabolism during sepsis through the downregulation of myocardial VLDL-R expression. (C) 2005 European Society of Cardiology. Published by Elsevier B.V. All rights reserved.